Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RYVU Therapeutics S.A. Board/Management Information 2021

Aug 26, 2021

5798_rns_2021-08-26_e92539a7-cc19-4886-8b66-6dc8e31dc4a8.html

Board/Management Information

Open in viewer

Opens in your device viewer

Resignationof the Member of the Management BoardTheManagement Board of Ryvu Therapeutics S.A. with its registered Office inKrakow ("Company"), informs that on 25th of August, 2021theCompany has received from Ms. Setareh Shamsili a letter of resignationfrom the position of a Member of the Management Board of the Company,effective as of 31 August 2021. The resignation was submitted due topersonal reasons.Legalbasis:§ 5point 4 of the Regulation of the Minister of Finance of 29 March 2018 oncurrent and periodic information published by issuers of securities andconditions for recognizing as equivalent information required by the lawof a non-member state(Journal of Laws of 2018, item 757).